The Vietnam market contributed JPY12.5 billion (US$79 million) to the revenue of Japanese retailer Aeon Mall last year, the largest in ASEAN and third highest globally. The figure went up 13.7% from ...
AEON Biopharma shares are trading lower by 65% during Monday's session. The company announced the pricing of a $20 million offering. AEON Biopharma Inc AEON shares are trading lower by 65% to 19 ...
AEON Biopharma IRVINE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum ...
AEON Biopharma, Inc. is a biopharmaceutical company. It engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback